Literature DB >> 2909534

The role of caldesmon in the regulation of receptor capping in mouse T-lymphoma cell.

G Walker1, W G Kerrick, L Y Bourguignon.   

Abstract

Several complementary techniques, including immunocytochemical and immunobiochemical analyses, two-dimensional gel electrophoresis, and peptide mapping, were used in this study to examine the involvement of caldesmon in lymphocyte receptor capping. We have found a lymphoma 140-kDa polypeptide that is structurally similar to muscle caldesmon, suggesting that this polypeptide may be a lymphoma caldesmon. When lymphoma 140-kDa polypeptide is extracted from permeabilized cells using 25 mM MgCl2, capping is inhibited. Adding the 140-kDa protein or gizzard caldesmon back to the extracted cells restores their ability to cap. These findings suggest that actin-linked regulatory proteins such as caldesmon may be critically important to actomyosin-mediated contraction which, in turn, is responsible for collecting receptors into cap structures.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2909534

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Caldesmon tethers myosin V to actin and facilitates in vitro motility.

Authors:  Brian Nibbelink; Mark E Hemric; Joe R Haeberle
Journal:  J Muscle Res Cell Motil       Date:  2004       Impact factor: 2.698

2.  Phosphatidylserine liposomes can be tethered by caldesmon to actin filaments.

Authors:  R Makuch; A Zasada; K Mabuchi; K Krauze; C L Wang; R Dabrowska
Journal:  Biophys J       Date:  1997-09       Impact factor: 4.033

3.  High-yield isolation of functionally competent endosomes from mouse lymphocytes.

Authors:  B D Beaumelle; C R Hopkins
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

4.  Interaction of caldesmon with endoplasmic reticulum membrane: effects on the mobility of phospholipids in the membrane and on the phosphatidylserine base-exchange reaction.

Authors:  P Makowski; R Makuch; A F Sikorski; A Jezierski; S Pikula; R Dabrowska
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

5.  Kinetics of binding of caldesmon to actin.

Authors:  J M Chalovich; Y D Chen; R Dudek; H Luo
Journal:  J Biol Chem       Date:  1995-04-28       Impact factor: 5.157

6.  Phosphorylation by casein kinase II affects the interaction of caldesmon with smooth muscle myosin and tropomyosin.

Authors:  N V Bogatcheva; A V Vorotnikov; K G Birukov; V P Shirinsky; N B Gusev
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

7.  Characterization of a caldesmon fragment that competes with myosin-ATP binding to actin.

Authors:  L Velaz; Y D Chen; J M Chalovich
Journal:  Biophys J       Date:  1993-08       Impact factor: 4.033

Review 8.  Caldesmon as a therapeutic target for proliferative vascular diseases.

Authors:  Chi-Ming Hai
Journal:  Mini Rev Med Chem       Date:  2008-10       Impact factor: 3.862

9.  Reversal of caldesmon binding to myosin with calcium-calmodulin or by phosphorylating caldesmon.

Authors:  M E Hemric; F W Lu; R Shrager; J Carey; J M Chalovich
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

10.  Modulation of actin mechanics by caldesmon and tropomyosin.

Authors:  M J Greenberg; C-L A Wang; W Lehman; J R Moore
Journal:  Cell Motil Cytoskeleton       Date:  2008-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.